| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −8.3× | −1.7× | |
| Price / Book | 2.5× | 2.0× | |
| Price / Sales | 1,378.5× | 3.9× | |
| Price / Free cash flow | −14.0× | −1.5× | |
| EV / EBITDA | −8.7× | −1.2× | |
| Earnings yield | −12.0% | −14.4% | |
| Free cash flow yield | −7.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.78 | +3.50% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.71 | +1.94% | $623.46B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.66 | +2.12% | $510.1B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.11 | +3.25% | $377.09B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.39 | +3.31% | $366.09B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.46 | +2.17% | $282.9B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.79 | +2.95% | $261.78B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $691.92 | +1.85% | $255.84B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.47 | +2.48% | $235.43B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.94 | +1.87% | $193.36B | 22.3× | 37.5% | +29.9% |
